These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2824604

  • 1. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
    Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, Komaroff AL, Ritz J.
    J Immunol; 1987 Nov 15; 139(10):3306-13. PubMed ID: 2824604
    [Abstract] [Full Text] [Related]

  • 2. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF, Triglia T, Werkmeister JA.
    J Immunol; 1984 Sep 15; 133(3):1656-63. PubMed ID: 6611374
    [Abstract] [Full Text] [Related]

  • 3. Induction of natural killer effectors from human thymus with recombinant IL-2.
    Michon JM, Caligiuri MA, Hazanow SM, Levine H, Schlossman SF, Ritz J.
    J Immunol; 1988 May 15; 140(10):3660-7. PubMed ID: 3258886
    [Abstract] [Full Text] [Related]

  • 4. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
    Smith BR, Rosenthal DS, Ault KA.
    Exp Hematol; 1985 Mar 15; 13(3):189-93. PubMed ID: 3884356
    [Abstract] [Full Text] [Related]

  • 5. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M, Williams PS, Solomon SD, Rubin AL, Stenzel KH.
    J Clin Invest; 1984 Dec 15; 74(6):2263-71. PubMed ID: 6392343
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.
    Ferrini S, Miescher S, Zocchi MR, von Fliedner V, Moretta A.
    J Immunol; 1987 Feb 15; 138(4):1297-302. PubMed ID: 3100633
    [Abstract] [Full Text] [Related]

  • 7. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA, Evans R, Kirkpatrick D, Lopez C.
    J Immunol; 1983 Apr 15; 130(4):1663-7. PubMed ID: 6601135
    [Abstract] [Full Text] [Related]

  • 8. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 9. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 10. Defective NK cell activity following thermal injury.
    Klimpel GR, Herndon DN, Fons M, Albrecht T, Asuncion MT, Chin R, Stein MD.
    Clin Exp Immunol; 1986 Nov 01; 66(2):384-92. PubMed ID: 3493101
    [Abstract] [Full Text] [Related]

  • 11. Natural killer cells and cytomegalovirus and Epstein-Barr virus infection in cardiac graft recipients.
    Korcáková L, Kaslík J, Svobodová J, Nozicková M, Horák J, Kocandrle V, Fabián J, Raska I, Lejnar J, Franková V.
    Cor Vasa; 1988 Nov 01; 30(6):435-41. PubMed ID: 2853033
    [Abstract] [Full Text] [Related]

  • 12. Lysis of human T cell leukemia virus infected T and B lymphoid cells by interleukin 2-activated killer cells.
    Froelich CJ, Guiffaut S.
    J Immunol; 1987 Dec 01; 139(11):3637-43. PubMed ID: 2824611
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
    Jones JF, Williams M, Schooley RT, Robinson C, Glaser R.
    Arch Intern Med; 1988 Sep 01; 148(9):1957-60. PubMed ID: 2843138
    [Abstract] [Full Text] [Related]

  • 14. Characterization of human large granular lymphocyte subpopulations: comparison of the phenotype of NK cells and of interleukin 2-dependent progenitors of cytolytic effector cells.
    Allavena P, Klein R, Ortaldo JR.
    Nat Immun Cell Growth Regul; 1985 Sep 01; 4(1):7-20. PubMed ID: 3875792
    [Abstract] [Full Text] [Related]

  • 15. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S.
    J Clin Lab Immunol; 1993 Sep 01; 40(2):47-60. PubMed ID: 7932628
    [Abstract] [Full Text] [Related]

  • 16. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, Mavilio D, De Filippi F, Bruno S, Mondelli MU.
    Gastroenterology; 2009 Sep 01; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [Abstract] [Full Text] [Related]

  • 17. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
    Schmidt RE, Bartley G, Levine H, Schlossman SF, Ritz J.
    J Immunol; 1985 Aug 01; 135(2):1020-5. PubMed ID: 3924996
    [Abstract] [Full Text] [Related]

  • 18. Low natural killer syndrome: clinical and immunologic features.
    Aoki T, Usuda Y, Miyakoshi H, Tamura K, Herberman RB.
    Nat Immun Cell Growth Regul; 1987 Aug 01; 6(3):116-28. PubMed ID: 2442602
    [Abstract] [Full Text] [Related]

  • 19. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A, Bertoglio J, Quillet A, Marchiol C, Wakasugi H, Mishall Z, Fradelizi D.
    J Immunol; 1986 Apr 01; 136(7):2463-9. PubMed ID: 3005412
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM, Tilden AB, Dougherty PA, Cloud GA, Abo T.
    Surgery; 1984 Jan 01; 95(1):63-70. PubMed ID: 6581546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.